Preface
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
i-i
Author(s):
P. Jeffrey Conn
Disorders of Tetrahydrobiopterin Metabolism and their Treatment
Journal:
Current Drug Metabolism
Volume:
3
Page:
123-131
Author(s):
H. Shintaku
Neopterin as a Marker for Immune System Activation
Journal:
Current Drug Metabolism
Volume:
3
Page:
175-187
Author(s):
C. Murr, B. Widner, B. Wirleitner and D. Fuchs
Aspartic Proteinases in Disease: A Structural Perspective
Journal:
Current Drug Targets
Volume:
3
Page:
155-173
Author(s):
J. B. Cooper
The Prediction of Amphiphilic α-Helices
Journal:
Current Protein & Peptide Science
Volume:
3
Page:
201-221
Author(s):
D. A. Phoenix, F. Harris, O. A. Daman and J. Wallace
Nicotinic Agonists and Psychosis
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
149-162
Author(s):
J. K. Simosky, K. E. Stevens and R. Freedman
Preclinical Pharmacology of mGlu2 / 3 Receptor Agonists: Novel Agents for Schizophrenia?
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
215-225
Author(s):
Darryle D. Schoepp and Gerard J. Marek
Schizophrenia: Genesis, Receptorology and Current Therapeutics
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
521-548
Author(s):
B. Capuano, I. T. Crosby and E. J. Lloyd
Glutamate and Schizophrenia: Pathophysiology and Therapeutics
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
29-44
Author(s):
G. J. Marek
New Perspectives on the Structure and Function of the Na+ Channel Multigene Family
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
59-81
Author(s):
Nobukuni Ogata and Shigeru Yoshida